These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3944383)

  • 1. An investigation of the H1-receptor antagonist triprolidine: pharmacokinetics and antihistaminic effects.
    Simons KJ; Singh M; Gillespie CA; Simons FE
    J Allergy Clin Immunol; 1986 Feb; 77(2):326-30. PubMed ID: 3944383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic and pharmacokinetics of BW 825C: a new antihistamine.
    Cohen AF; Hamilton MJ; Liao SH; Findlay JW; Peck AW
    Eur J Clin Pharmacol; 1985; 28(2):197-204. PubMed ID: 2859204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics and antihistaminic effects of brompheniramine.
    Simons FE; Frith EM; Simons KJ
    J Allergy Clin Immunol; 1982 Dec; 70(6):458-64. PubMed ID: 6128358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acrivastine and terfenadine on skin reactivity to histamine.
    Leynadier F; Murrieta M; Dry J; Colin JN; Gillotin C; Steru D
    Ann Allergy; 1994 Jun; 72(6):520-4. PubMed ID: 7911286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of terfenadine and chlorpheniramine in the elderly.
    Simons KJ; Martin TJ; Watson WT; Simons FE
    J Allergy Clin Immunol; 1990 Mar; 85(3):540-7. PubMed ID: 2107240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine.
    Simons FE; Simons KJ; Frith EM
    J Allergy Clin Immunol; 1984 Jan; 73(1 Pt 1):69-75. PubMed ID: 6141198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic studies of the H1-receptor antagonist hydroxyzine in the elderly.
    Simons KJ; Watson WT; Chen XY; Simons FE
    Clin Pharmacol Ther; 1989 Jan; 45(1):9-14. PubMed ID: 2562944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics and pharmacodynamics of hydroxyzine in patients with primary biliary cirrhosis.
    Simons FE; Watson WT; Chen XY; Minuk GY; Simons KJ
    J Clin Pharmacol; 1989 Sep; 29(9):809-15. PubMed ID: 2572611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudoephedrine and triprolidine in plasma and breast milk of nursing mothers.
    Findlay JW; Butz RF; Sailstad JM; Warren JT; Welch RM
    Br J Clin Pharmacol; 1984 Dec; 18(6):901-6. PubMed ID: 6529531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of Triprolidine as a Single Agent or in Combination With Pseudoephedrine: A Randomized, Open-Label Crossover Study in Healthy Volunteers.
    Febbraro S; Shea T; Cravo AS
    Clin Pharmacol Drug Dev; 2020 May; 9(4):486-495. PubMed ID: 32133778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of triprolidine in human plasma by quantitative TLC.
    DeAngelis RL; Kearney MF; Welch RM
    J Pharm Sci; 1977 Jun; 66(6):841-3. PubMed ID: 874787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of pseudoephedrine and triprolidine from combination and single-ingredient products.
    Williams BO; Liao SH; Lai AA; Arnold JD; Perkins JG; Blum MR; Findlay JW
    Clin Pharm; 1984; 3(6):638-43. PubMed ID: 6509877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of orally administered triprolidine and pseudoephedrine singly and combined on histamine-induced skin reactions.
    Gibson JR; Medder KT; McDonnell KA; Bye CE; Hughes DT
    Eur J Clin Pharmacol; 1982; 22(5):411-2. PubMed ID: 6180901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of triprolidine and clemastine on histamine antagonism and performance tests in man: implications for the mechanism of drug induced drowsiness.
    Peck AW; Fowle AS; Bye C
    Eur J Clin Pharmacol; 1975 Aug; 8(6):455-63. PubMed ID: 1233248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oral and transdermal triprolidine.
    Miles MV; Balasubramanian R; Pittman AW; Grossman SH; Pappa KA; Smith MF; Wargin WA; Findlay JW; Poust RI; Frosolono MF
    J Clin Pharmacol; 1990 Jun; 30(6):572-5. PubMed ID: 2355108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of triprolidine and cyclizine on histamine (H1) antagonism, subjective effects and performance tests in man.
    Hamilton M; Bush M; Bye C; Peck AW
    Br J Clin Pharmacol; 1982 Mar; 13(3):441-4. PubMed ID: 6120718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine.
    Ballmer-Weber BK; Gex-Collet C; Wüthrich B
    J Investig Allergol Clin Immunol; 1999; 9(6):351-5. PubMed ID: 10664928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative gas chromatographic-mass spectrometric analysis of acrivastine and a metabolite in human plasma.
    Chang SY; Nelson FR; Findlay JW; Taylor LC
    J Chromatogr; 1989 Dec; 497():288-95. PubMed ID: 2576270
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial transformation of the antihistaminic drug triprolidine hydrochloride.
    Hansen EB; Heflich RH; Korfmacher WA; Miller DW; Cerniglia CE
    J Pharm Sci; 1988 Mar; 77(3):259-64. PubMed ID: 3286859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.